GPCRs 2020
DOI: 10.1016/b978-0-12-816228-6.00016-7
|View full text |Cite
|
Sign up to set email alerts
|

Tackling the complexities of orphan GPCR ligand discovery with rationally assisted approaches

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 385 publications
0
3
0
Order By: Relevance
“…Over 100 of the ∼800 known human G protein-coupled receptors (GPCRs) ( Fredriksson et al, 2003 ) lack a pairing to an endogenous ligand and are collectively known as ‘orphan’ receptors ( Davenport et al, 2013 ). Orphan GPCRs remain largely understudied ( So et al, 2020 ), owing mainly to the paucity of pharmacological tools available to probe receptor signaling. Many orphan receptors lack an adequate signaling assay, which is a significant roadblock to ligand discovery, and a further hindrance to identification of the physiological role of these orphan GPCRs in health and disease.…”
Section: Introductionmentioning
confidence: 99%
“…Over 100 of the ∼800 known human G protein-coupled receptors (GPCRs) ( Fredriksson et al, 2003 ) lack a pairing to an endogenous ligand and are collectively known as ‘orphan’ receptors ( Davenport et al, 2013 ). Orphan GPCRs remain largely understudied ( So et al, 2020 ), owing mainly to the paucity of pharmacological tools available to probe receptor signaling. Many orphan receptors lack an adequate signaling assay, which is a significant roadblock to ligand discovery, and a further hindrance to identification of the physiological role of these orphan GPCRs in health and disease.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, 2 additional subsets of the merged active prediction set were created that individually represented predictions made for ligands complexed with experimentally determined protein structures or predictions made for ligands complexes with modeled protein structures. For each set or subset of predictions, performance of the classifier was assessed with the precision (Equation (3)), accuracy (Equation ( 4)), and recall (Equation ( 5 (5) where TP, TN, FP, and FN are the numbers of true positives, true negatives, false positives, and false negatives, respectively, for each class of ligand activity. In addition, hit rates were calculated for the merged active prediction sets using Equation (1).…”
Section: Random Forest Classifier Developmentmentioning
confidence: 99%
“…However, FDAapproved drugs only target 108 of the 360 known "druggable" non-olfactory GPCRs [4], indicating that a substantial swath of GPCR targets are yet to be clinically leveraged. Furthermore, ~25% of GPCR are still classified as "orphans", signaling that they lack a known endogenous ligand and often possess an ambiguous or undefined physiological role [5]. For these understudied GPCRs, the ability to better understand and modulate their physiological roles may illuminate poorly characterized pathways relevant to the development, progression, and treatment of disease.…”
Section: Introductionmentioning
confidence: 99%
“…For example, phenotypic or second messenger amplification assays with the read-out many steps removed from receptor activation are vulnerable to non-specific signal interference, as was the case for p426-r37L1 1,4 , or to interference from the endogenous receptor context 6,7 . These are common challenges for orphan research 16,17 , which nevertheless should not deter us from continuing to define the pharmacology and physiology of GPR37L1 . Examination of constitutive and ligand-induced cAMP elevation in HEK293 cells transfected with or without the corrected pcDNA3.1-GPR37L1, using (a) CRE-luc or (b) CAMYEL assays.…”
mentioning
confidence: 99%